130 related articles for article (PubMed ID: 19477296)
1. Statistical model to estimate a threshold dose and its confidence limits for the analysis of sublinear dose-response relationships, exemplified for mutagenicity data.
Lutz WK; Lutz RW
Mutat Res; 2009 Aug; 678(2):118-22. PubMed ID: 19477296
[TBL] [Abstract][Full Text] [Related]
2. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
3. Non-linear dose-response of DNA-reactive genotoxins: recommendations for data analysis.
Johnson GE; Doak SH; Griffiths SM; Quick EL; Skibinski DO; Zaïr ZM; Jenkins GJ
Mutat Res; 2009 Aug; 678(2):95-100. PubMed ID: 19467345
[TBL] [Abstract][Full Text] [Related]
4. The Viracept (nelfinavir)--ethyl methanesulfonate case: a threshold risk assessment for human exposure to a genotoxic drug contamination?
Lutz WK
Toxicol Lett; 2009 Nov; 190(3):239-42. PubMed ID: 19695319
[TBL] [Abstract][Full Text] [Related]
5. Quantitative dose-response analysis of ethyl methanesulfonate genotoxicity in adult gpt-delta transgenic mice.
Cao X; Mittelstaedt RA; Pearce MG; Allen BC; Soeteman-Hernández LG; Johnson GE; Bigger CA; Heflich RH
Environ Mol Mutagen; 2014 Jun; 55(5):385-99. PubMed ID: 24535894
[TBL] [Abstract][Full Text] [Related]
6. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
7. Dose-response and operational thresholds/NOAELs for in vitro mutagenic effects from DNA-reactive mutagens, MMS and MNU.
Pottenger LH; Schisler MR; Zhang F; Bartels MJ; Fontaine DD; McFadden LG; Bhaskar Gollapudi B
Mutat Res; 2009 Aug; 678(2):138-47. PubMed ID: 19616119
[TBL] [Abstract][Full Text] [Related]
8. In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU.
Gocke E; Müller L
Mutat Res; 2009 Aug; 678(2):101-7. PubMed ID: 19376265
[TBL] [Abstract][Full Text] [Related]
9. Biological significance of DNA adducts: comparison of increments over background for various biomarkers of genotoxicity in L5178Y tk(+/-) mouse lymphoma cells treated with hydrogen peroxide and cumene hydroperoxide.
Brink A; Richter I; Lutz U; Wanek P; Stopper H; Lutz WK
Mutat Res; 2009 Aug; 678(2):123-8. PubMed ID: 19539047
[TBL] [Abstract][Full Text] [Related]
10. In vivo genotoxicity of EMS: statistical assessment of the dose response curves.
Gocke E; Wall M
Toxicol Lett; 2009 Nov; 190(3):298-302. PubMed ID: 19857797
[TBL] [Abstract][Full Text] [Related]
11. Tests for genotoxicity and mutagenicity of furan and its metabolite cis-2-butene-1,4-dial in L5178Y tk+/- mouse lymphoma cells.
Kellert M; Brink A; Richter I; Schlatter J; Lutz WK
Mutat Res; 2008 Dec; 657(2):127-32. PubMed ID: 18804178
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cancer slope factors using different statistical approaches.
Subramaniam RP; White P; Cogliano VJ
Risk Anal; 2006 Jun; 26(3):825-30. PubMed ID: 16834636
[TBL] [Abstract][Full Text] [Related]
13. Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate.
Gocke E; Bürgin H; Müller L; Pfister T
Toxicol Lett; 2009 Nov; 190(3):254-65. PubMed ID: 19857796
[TBL] [Abstract][Full Text] [Related]
14. Statistical analysis of in vitro data for risk assessment - exemplified for a case of Ames test data.
Roller M; Aufderheide M
Exp Toxicol Pathol; 2008 Jun; 60(2-3):213-24. PubMed ID: 18396021
[TBL] [Abstract][Full Text] [Related]
15. Studies on the activities of benzo[a]pyrene, benzidine and ethyl methanesulphonate in the L5178Y TK +/- mouse lymphoma mutagenicity assay using standardized and non-standardized protocols.
Riach CG; Cattanach PJ; Howgate S; Shepherd W; McBride D; Edwards IW; McGregor DB; Combes RD
Mutagenesis; 1990; 5 Suppl():35-44. PubMed ID: 2184319
[TBL] [Abstract][Full Text] [Related]
16. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
17. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
Zhu Y; Wang T; Jelsovsky JZ
Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
[TBL] [Abstract][Full Text] [Related]
18. Biological significance of DNA adducts investigated by simultaneous analysis of different endpoints of genotoxicity in L5178Y mouse lymphoma cells treated with methyl methanesulfonate.
Brink A; Schulz B; Stopper H; Lutz WK
Mutat Res; 2007 Dec; 625(1-2):94-101. PubMed ID: 17586535
[TBL] [Abstract][Full Text] [Related]
19. Quantitative approaches for assessing dose-response relationships in genetic toxicology studies.
Gollapudi BB; Johnson GE; Hernandez LG; Pottenger LH; Dearfield KL; Jeffrey AM; Julien E; Kim JH; Lovell DP; Macgregor JT; Moore MM; van Benthem J; White PA; Zeiger E; Thybaud V
Environ Mol Mutagen; 2013 Jan; 54(1):8-18. PubMed ID: 22987251
[TBL] [Abstract][Full Text] [Related]
20. Implications of arsenic genotoxicity for dose response of carcinogenic effects.
Rudel R; Slayton TM; Beck BD
Regul Toxicol Pharmacol; 1996 Apr; 23(2):87-105. PubMed ID: 8661328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
